Overview

Vitamin D Nasal Drops in Post COVID Parosmia

Status:
Not yet recruiting

Trial end date:
2022-12-01

Target enrollment:

Participant gender:

Summary

The current study will be a pilot study for a randomized controlled trial conducted on patients recruited from the outpatient clinic of the Otorhinolaryngology Department, Menoufia Faculty of Medicine To evaluate the effect of vitamin D nasal drops in the treatment of post COVID 19 parosmia

Phase:

Phase 2

Details

Lead Sponsor:

Menoufia University

Treatments:

Budesonide
Cholecalciferol
Vitamin D